Based in Howell, New Jersey, Kenneth D. Nahum, DO, treats cancer and blood disease patients as a member of Regional Cancer Care Associates, LLC. Having served as principal investigator in a variety of clinical trials, Dr. Kenneth D. Nahum has undertaken research on the health behaviors of patients diagnosed with colorectal cancer.
Encompassing the full range of cancers involving the rectum and colon, colorectal cancer impacts more than 4 percent of men and women nationwide. Recent research undertaken at Ninewells Hospital in Dundee, Scotland, focuses on fecal occult blood tests and the medical records of approximately 130,000 patients over a 16-year period.
As expected, the 2,700 tests that came back positive for minute traces of blood in the stool correlated strongly with colon cancer with a related risk of mortality seven times higher than those without positive results. A surprise finding was that a significant non-colorectal cancer mortality correlation also existed. Overall, those who tested positive had a 58 percent greater likelihood to die over the 16 years covered by the test.
A hypothesis is that blood in the stool may be associated with generalized inflammation associated with diverse conditions such as diabetes, heart disease, and Alzheimer’s disease, as well as colorectal cancer.
Encompassing the full range of cancers involving the rectum and colon, colorectal cancer impacts more than 4 percent of men and women nationwide. Recent research undertaken at Ninewells Hospital in Dundee, Scotland, focuses on fecal occult blood tests and the medical records of approximately 130,000 patients over a 16-year period.
As expected, the 2,700 tests that came back positive for minute traces of blood in the stool correlated strongly with colon cancer with a related risk of mortality seven times higher than those without positive results. A surprise finding was that a significant non-colorectal cancer mortality correlation also existed. Overall, those who tested positive had a 58 percent greater likelihood to die over the 16 years covered by the test.
A hypothesis is that blood in the stool may be associated with generalized inflammation associated with diverse conditions such as diabetes, heart disease, and Alzheimer’s disease, as well as colorectal cancer.
